Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
immunology and microbiology
Tuberculosis incidence in foreign-born people residing in European countries in 2020
Eurosurveillance, Volume 28, No. 42, Article 2300051, Year 2023
Notification
URL copied to clipboard!
Description
Background: European-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening. Aim: We aimed to identify groups of foreign-born individuals residing in European countries that benefit most from targeted TB prevention screening. Methods: The Tuberculosis Network European Trials group collected, by cross-sectional survey, numbers of foreign-born TB patients residing in European Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) in 2020 from the 10 highest ranked countries of origin in terms of TB cases in each country of residence. Tuberculosis incidence rates (IRs) in countries of residence were compared with countries of origin. Results: Data on 9,116 foreign-born TB patients in 30 countries of residence were collected. Main countries of origin were Eritrea, India, Pakistan, Morocco, Romania and Somalia. Tuberculosis IRs were highest in patients of Eritrean and Somali origin in Greece and Malta (both>1,000/100,000) and lowest among Ukrainian patients in Poland (3.6/100,000). They were mainly lower in countries of residence than countries of origin. However, IRs among Eritreans and Somalis in Greece and Malta were five times higher than in Eritrea and Somalia. Similarly, IRs among Eritreans in Germany, the Netherlands and the UK were four times higher than in Eritrea. Conclusions: Country of origin TB IR is an insufficient indicator when targeting foreign-born populations for active case finding or TB prevention policies in the countries covered here. Elimination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks. © 2023 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
Authors & Co-Authors
Vasiliu, Anca
United States, Houston
Baylor College of Medicine
Altpeter, Ekkehardt Siegfried
Switzerland, Bern
Federal Office of Public Health Foph
Ægisdóttir, Tinna Rán
Iceland, Reykjavik
Landspitali - the National University Hospital of Iceland
de Oñate, Wouter Arrázola
Belgium, Brussels
Belgian Lung and Tuberculosis Association
Bakos, Ágnes
Unknown Affiliation
van Crevel, Reinout
Netherlands, Nijmegen
Radboud University Medical Center
United Kingdom, Oxford
University of Oxford
Davidaviciene, Edita
Lithuania, Vilnius
Vilniaus Universitetas
Domínguez, José A.Blanco
Spain, Madrid
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
Duarte, R. A.B.
Portugal, Porto
Universidade do Porto
Portugal, Vila Nova de Gaia
Centro Hospitalar de Vila Nova de Gaia
Günther, Gunar
Switzerland, Bern
University of Bern
Namibia, Windhoek
University of Namibia
Guthmann, Jean Paul
France, Saint-maurice
Santé Publique France
Herrador, Zaida
Spain, Madrid
Instituto de Salud Carlos Iii
Ibraim, Elmira
Romania, Bucharest
Marius Nasta Institute of Pulmonology
Jackson, Sarah
Ireland, Dublin
Health Service Executive Ireland
Jensenius, Mogens
Norway, Oslo
Oslo Universitetssykehus
Korzeniewska-Koseła, Maria
Poland, Warsaw
National Institute of Tuberculosis and Lung Diseases, Warszawa
Kukša, Liga
Latvia, Riga
Rīgas Austrumu Klīniskā Universitātes Slimnīca
Kunst, Heinke
United Kingdom, London
Queen Mary University of London
Lienhardt, Christian
France, Montpellier
Université de Montpellier
United Kingdom, London
London School of Hygiene & Tropical Medicine
Jankovic Makek, Mateja
Croatia, Zagreb
University of Zagreb
Croatia, Zagreb
Kbc Zagreb
Muylle, Inge
Belgium, Aalst
Onze Lieve Vrouw Hospital
Normark, Johan
Sweden, Umea
Umeå Universitet
Pace-Asciak, Analita
Unknown Affiliation
Pieridou, Despo
Cyprus, Nicosia
Ministry of Health Cyprus
Salzer, Helmut J.F.
Austria, Linz
Kepler Universitätsklinikum
Austria, Linz
Johannes Kepler University Linz
Solovič, Ivan
Slovakia, Ruzomberok
Katolícka Univerzita V Ružomberku
Sukholytka, Mariia
Czech Republic, Prague
Fakultni Thomayerova Nemocnice
Svetina, Petra
Slovenia, Golnik
Bolnišnica Golnik
Vasankari, Tuula M.
Finland, Turku
Turun Yliopisto
Finland, Helsinki
Finnish Lung Health Association
Viiklepp, Piret
Estonia, Tallinn
Tervise Arengu Instituut
Mandalakas, A. M.
United States, Houston
Baylor College of Medicine
Germany, Borstel
Forschungszentrum Borstel - Zentrum Für Medizin Und Biowissenschaften
Martinez, Leonardo
United States, Boston
Boston University
Zenner, Dominik
United Kingdom, London
Queen Mary University of London
Lange, Christoph G.
United States, Houston
Baylor College of Medicine
Germany, Borstel
Forschungszentrum Borstel - Zentrum Für Medizin Und Biowissenschaften
Germany, Borstel
German Center for Infection Research Dzif
Germany, Lubeck
Universität zu Lübeck
Statistics
Citations: 2
Authors: 34
Affiliations: 49
Identifiers
Doi:
10.2807/1560-7917.ES.2023.28.42.2300051
ISSN:
1025496X
Research Areas
Infectious Diseases
Study Design
Cross Sectional Study
Cohort Study
Study Approach
Quantitative
Study Locations
Eritrea
Morocco
Somalia